| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer | Chief Medical Officer
1 company
Morrell Martha is a Chief Medical Officer at NeuroPace Inc. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $1.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21, 2025 | NPCE Neuropace Inc | Chief Medical Officer | Sell | 78,334 | $13.72 | $1,074,844.31 | -48.9% | +29.8% | +4.1% | |
| Jan 30, 2025 | NPCE Neuropace Inc | Chief Medical Officer | Sell | 300 | $15.00 | $4,500.00 | -0.2% | -17.6% | +6.6% | |
| Jan 24, 2025 | NPCE Neuropace Inc | Chief Medical Officer | Sell | 3,200 | $15.01 | $48,032.00 | -3.5% | -23.4% | +13.8% | |
| Feb 5, 2024 | NPCE Neuropace Inc | Chief Medical Officer | Sell | 17,589 | $15.09 | $265,400.51 | -10.0% | -12.6% | -9.9% | |
| Feb 1, 2024 | NPCE Neuropace Inc | Chief Medical Officer | Sell | 13,848 | $15.09 | $208,965.06 | -4.6% | -6.8% | -8.2% | |
| Jan 25, 2024 | NPCE Neuropace Inc | Chief Medical Officer | Sell | 828 | $15.02 | $12,440.68 | -0.4% | -7.0% | +0.7% | |
| Dec 27, 2023 | NPCE Neuropace Inc | Chief Medical Officer | Sell | 13,402 | $10.12 | $135,667.87 | -5.4% | +32.5% | +12.8% | |
| Dec 20, 2023 | NPCE Neuropace Inc | Chief Medical Officer | Sell | 2,730 | $10.14 | $27,695.30 | -2.2% | +45.1% | +20.2% | |
| Dec 6, 2023 | NPCE Neuropace Inc | Chief Medical Officer | Sell | 11,005 | $8.16 | $89,773.29 | -8.0% | +72.7% | +37.2% |